Generic Name: Galsulfase (Drug Plan Submission)
Brand Name: Naglazyme
Manufacturer: BioMarin Pharmaceutical (Canada) Inc.
Indications: Mucopolysaccharidosis VI
Submission Type: New
Project Status: Complete
Date Recommendation Issued: February 19, 2016
Recommendation Type: List with clinical criteria and/or conditions